Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EVH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early progress on major client launches and continued investment in automation.
| Health Care Technology Industry | Healthcare Sector | Seth Barrie Blackley CEO | XDUS Exchange | US30050B1017 ISIN |
| US Country | 4,200 Employees | - Last Dividend | - Last Split | 5 Jun 2015 IPO Date |
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, specializes in providing specialty care management services targeted at oncology, cardiology, and musculoskeletal markets across the United States. With a focus on transforming the healthcare delivery system, the company leverages its platform for health plan administration and value-based care to enhance the efficiency and quality of healthcare services. Founded in 2011, Evolent Health is dedicated to supporting healthcare organizations in managing their populations and navigating the complex healthcare environment. The company is headquartered in Arlington, Virginia, positioning itself as a key player in the healthcare sector by offering innovative solutions designed to improve patient outcomes and reduce healthcare costs.
Evolent Health, Inc. offers a comprehensive suite of products and services that cater to the various needs of healthcare organizations, including: